Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Uveal Melanoma × AZD 6244 × Clear all

Phase

Status

Sponsor Class

OTHER 1 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 7 Neurofibromatosis 1 6 Neoplasm Metastasis 6 Solid Tumours 5 Neoplasms 5 Melanoma 5 Neurofibroma, Plexiform 4 Lung Neoplasms 3 Colorectal Neoplasms 3 Breast Neoplasms 2 Biliary Tract Neoplasms 2 Uveal Melanoma 1 Solid Tumors 1 Renal Insufficiency 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Muscle Invasive Bladder Cancer 1 Locally Advanced or Metastatic Solid Tumors 1 Kidney Neoplasms 1 Healthy Volunteers Pharmacokinetic Study 1 Disease Progression 1 Differentiated Thyroid Cancer 1 Colonic Neoplasms 1 Advanced Non Small Cell Lung Cancer 1 Advanced Cancer 1

Interventions

pembrolizumab 7 Ipilimumab 7 Nivolumab 5 Melphalan 5 Dacarbazine 3 tebentafusp 2 sotrastaurin 2 binimetinib 2 Pemetrexed 2 Crizotinib 2 ADI PEG20 2 utomilumab 1 trametinib 1 tocilizumab 1 siremadlin 1 ruxolitinib 1 relatlimab 1 obinutuzumab 1 cemiplimab 1 avelumab 1 Watchful Waiting 1 Toll-Like Receptor 1 1 Standard of Care 1 Solutions 1 Rose Bengal 1 Protein Kinase C 1 Polyethylene Glycols 1 Opdualag 1 Neoadjuvant Therapy 1 Monophenol Monooxygenase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01974752 2017-01-05

SUMIT

AstraZeneca

Phase 3 Completed

152 enrolled 14 charts

Uveal Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡